Infect Chemother.  2014 Mar;46(1):50-53. 10.3947/ic.2014.46.1.50.

Simultaneous Chylothorax and Chylous Ascites Due to Tuberculosis

Affiliations
  • 1Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea. cmcws@hanmail.net

Abstract

Chylothorax or chylous ascites is rare manifestation of tuberculosis. We report a case of simultaneous chylothorax and chylous ascites due to tuberculosis. A 17-year-old girl was admitted with fever, abdominal distention and dyspnea. Chest and abdominal computed tomography revealed bilateral pleural effusion, multifocal nodular consolidation on both lung fields and copious ascites and multiple necrotic lymphadenopathy in the abdominal cavity. Mycobacterium tuberculosis was isolated from sputum and pleural fluid. The patient was treated with anti-tuberculosis medication. Pleural effusion and ascites improved with the medication.

Keyword

Chylothorax; Chylous ascites; Tuberculosis

MeSH Terms

Abdominal Cavity
Adolescent
Ascites
Chylothorax*
Chylous Ascites*
Dyspnea
Female
Fever
Humans
Lung
Lymphatic Diseases
Mycobacterium tuberculosis
Pleural Effusion
Sputum
Thorax
Tuberculosis*

Figure

  • Figure 1 Contrast-enhanced computed tomography (CT) scan images. (A) Chest CT scan showed left side dominant pleural effusion and multifocal mediastinal lymph node enlargement. (B) Abdominal CT scan showed large amount of ascites with diffuse peritoneal thickening and multiple necrotic lymphadenopathy in the abdominal cavity suggesting tuberculous peritonitis with lymphadenopathy.

  • Figure 2 Appearance of pleural fluid and ascites. (A) Pleural fluid drained by diagnostic thoracentesis, milk-like appearance. (B) Ascties drained by diagnostic paracentesis, whitish or opalescent looking rich in triglyceride.


Reference

1. Cárdenas A, Chopra S. Chylous ascites. Am J Gastroenterol. 2002; 97:1896–1900.
Article
2. Aalami OO, Allen DB, Organ CH Jr. Chylous ascites: a collective review. Surgery. 2000; 128:761–778.
Article
3. Valentine VG, Raffin TA. The management of chylothorax. Chest. 1992; 102:586–591.
Article
4. Press OW, Press NO, Kaufman SD. Evaluation and management of chylous ascites. Ann Intern Med. 1982; 96:358–364.
Article
5. Romero S, Martín C, Hernandez L, Verdu J, Trigo C, Perez-Mateo M, Alemany L. Chylothorax in cirrhosis of the liver: analysis of its frequency and clinical characteristics. Chest. 1998; 114:154–159.
6. Nix JT, Albert M, Dugas JE, Wendt DL. Chylothorax and chylous ascites; a study of 302 selected cases. Am J Gastroenterol. 1957; 28:40–53. discussion, 53-5.
7. Lee CK, Han JM, Lee KN, Lee EY, Shin JH, Cho YS, Koh Y, Yoo B, Moon HB. Concurrent occurrence of chylothorax, chylous ascites, and protein-losing enteropathy in systemic lupus erythematosus. J Rheumatol. 2002; 29:1330–1333.
8. Cakir E, Gocmen B, Uyan ZS, Oktem S, Kiyan G, Karakoc F, Ersu R, Karadag B, Dagli T, Dagli E. An unusual case of chylothorax complicating childhood tuberculosis. Pediatr Pulmonol. 2008; 43:611–614.
Article
9. Lee TH, Lee EY, Cho YS, Yoo B, Moon HB, Lee CK. Concurrent occurrence of chylothorax and chylous ascites in a patient with Henoch-Sch?nlein purpura. Scand J Rheumatol. 2003; 32:378–379.
Article
10. Doerr CH, Allen MS, Nichols FC 3rd, Ryu JH. Etiology of chylothorax in 203 patients. Mayo Clin Proc. 2005; 80:867–870.
Article
11. Antón PA, Rubio J, Casán P, Franquet T. Chylothorax due to Mycobacterium tuberculosis. Thorax. 1995; 50:1019.
12. Vennera MC, Moreno R, Cot J, Marin A, Sanchez-Lloret J, Picado C, Agusti-Vidal A. Chylothorax and tuberculosis. Thorax. 1983; 38:694–695.
Article
13. Bond SJ, Guzzetta PC, Snyder ML, Randolph JG. Management of pediatric postoperative chylothorax. Ann Thorac Surg. 1993; 56:469–472. discussion 472-3.
Article
14. Shah D, Sinn JK. Octreotide as therapeutic option for congenital idiopathic chylothorax: a case series. Acta Paediatr. 2012; 101:e151–e155.
Article
15. Foo NH, Hwang YS, Lin CC, Tsai WH. Congenital chylothorax in a late preterm infant and successful treatment with octreotide. Pediatr Neonatol. 2011; 52:297–301.
Article
16. Zhou DX, Zhou HB, Wang Q, Zou SS, Wang H, Hu HP. The effectiveness of the treatment of octreotide on chylous ascites after liver cirrhosis. Dig Dis Sci. 2009; 54:1783–1788.
Article
17. Ijichi H, Soejima Y, Taketomi A, Yoshizumi T, Uchiyama H, Harada N, Yonemura Y, Maehara Y. Successful management of chylous ascites after living donor liver transplantation with somatostatin. Liver Int. 2008; 28:143–145.
Article
18. Baran M, Cakir M, Yüksekkaya HA, Arikan C, Aydin U, Aydogdu S, Kilic M. Chylous ascites after living related liver transplantation treated with somatostatin analog and parenteral nutrition. Transplant Proc. 2008; 40:320–321.
Article
19. Berzigotti A, Magalotti D, Cocci C, Angeloni L, Pironi L, Zoli M. Octreotide in the outpatient therapy of cirrhotic chylous ascites: a case report. Dig Liver Dis. 2006; 38:138–142.
Article
Full Text Links
  • IC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr